Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Realm Therapeutics PLC    PURI   GB00B3XBCR18

REALM THERAPEUTICS PLC (PURI)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
09/18/2018 09/19/2018 09/20/2018 09/21/2018 09/24/2018 Date
9.25(c) 9.75(c) 9.75(c) 9.75(c) 9.75 Last
45 000 2 653 920 605 000 859 338 0 Volume
-2.63% +5.41% 0.00% 0.00% 0.00% Change
More quotes
Financials (GBP)
Sales 2018 0,81 M
EBIT 2018 -
Net income 2018 -
Finance 2018 15,5 M
Yield 2018 -
Sales 2019 0,81 M
EBIT 2019 -
Net income 2019 -
Finance 2019 2,21 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 -5,12x
EV / Sales2019 11,3x
Capitalization 11,4 M
More Financials
Company
Realm Therapeutics Plc is a clinical stage biopharmaceutical company, which engages in the development of novel therapeutics for immunemediated diseases.It focusThe company was founded on April 21, 2006 and is headquartered in Malvern, PA. 
More about the company
Latest news on REALM THERAPEUTICS PLC
09/17REALM THERAPEUTICS : Corporate Update and Hiring of Advisor
PU
08/16REALM THERAPEUTICS : faces another Phase 2 failure in eczema
AQ
08/16REALM THERAPEUTICS : shares crater again on a failed PhII atopic dermatitis stud..
AQ
08/14REALM THERAPEUTICS : Half-year Report
PU
08/08REALM THERAPEUTICS : Presents at Wedbush PacGrow Healthcare Conference
PU
08/07REALM THERAPEUTICS : Notice of Results
PU
07/14REALM THERAPEUTICS : Announces Publication of Pre-Clinical Study Demonstrating C..
AQ
07/12REALM THERAPEUTICS : Announces U.S. SEC Declares Registration Statement Effectiv..
AQ
07/10REALM THERAPEUTICS : Pre-Clinical Study in Atopic Dermatitis
PU
07/05REALM THERAPEUTICS : Patent Issued for Methods and Compositions for Treating Inf..
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug in First European Setback -..
DJ
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug for Some Patients Despite D..
DJ
09/19GILEAD SCIENCES : UK rejects adult Novartis CAR-T therapy, after 'yes' in kids
RE
09/18REGENERON PHARMACEUTICALS : Sanofi pledges to keep up its restructuring efforts
RE
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans
DJ
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
09/18UPSIDE MOMENTUM ALERT: $RLM REALM THERAPEUTICS PLC ADS ? TradeIdeas via  
09/17After back-to-back trial flops, Realm slashes its staff, halts research work .. 
09/17Realm Therapeutics provides corporate update and hires advisor to support str.. 
09/17Realm Therapeutics Provides Corporate Update and Hires Advisor to Support Str.. 
09/17Realm Therapeutics launches review that may include a sale after disappointin.. 
More tweets
Qtime:22
Chart REALM THERAPEUTICS PLC
Duration : Period :
Realm Therapeutics PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REALM THERAPEUTICS PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers
NameTitle
John Alexander Martin Chief Executive Officer & Executive Director
Charles Alexander Evan Spicer Non-Executive Chairman
Marella Thorell COO, CFO, Secretary & Executive Director
Christian Peters Chief Medical Officer
Joseph William Birkett Senior Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
REALM THERAPEUTICS PLC-73.65%15
CELLTRION, INC.--.--%33 388
IQVIA HOLDINGS INC30.32%25 763
LONZA GROUP18.80%24 291
INCYTE CORPORATION-29.69%14 156
SEATTLE GENETICS, INC.45.35%12 348